Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame
Primary	Myocardial perfusion determined by CMR	3 days
Secondary	Final infarct size determined by CMR	3 days
Secondary	Left ventricular function determined by CMR	3 days/ 6 months (6-months Remodeling-substudy)
Secondary	Plasma NT-BNP	30 days/ 6 months (6-months substudy)
Secondary	Enzymatic infarct size (CK levels)	3 days
Secondary	ECG ST-segment resolution	1 hour
Secondary	Markers of inflammation	24 hours/ 30 days
Secondary	Major adverse cardiac events (MACE) (cardiovascular death, re-hospitalization for unstable angina and AMI, hospitalization for worsening heart failure)	30 days
Secondary	Liver function	24hours/ 3 days/ 30 days
Secondary	Event free survival	6 months (6-months substudy)
Secondary	Holter ECG	3 days / 30 days (EP-substudy)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00502528/registered